Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Immunovia and OHSU team up to validate, commercialize blood test for early diagnosis of pancreatic cancer

Immunovia and OHSU team up to validate, commercialize blood test for early diagnosis of pancreatic cancer

Penn study forms basis for new treatment approaches for Sezary syndrome

Penn study forms basis for new treatment approaches for Sezary syndrome

Dr. Paul Liu named 2015 Distinguished Alumnus for contributions to leukemia research

Dr. Paul Liu named 2015 Distinguished Alumnus for contributions to leukemia research

IU-led scientists discover new gene that increases Alzheimer's disease risk

IU-led scientists discover new gene that increases Alzheimer's disease risk

HLA-DPB1 regulatory region genotype predicts acute GVHD

HLA-DPB1 regulatory region genotype predicts acute GVHD

Beta-catenin shows treatment target potential for TKI-resistant CML

Beta-catenin shows treatment target potential for TKI-resistant CML

Two studies identify promising new anti-retroviral strategy to combat HIV-1

Two studies identify promising new anti-retroviral strategy to combat HIV-1

New study finds that serum miRNA profiles change as myeloma progresses

New study finds that serum miRNA profiles change as myeloma progresses

Collaborative program aims at reducing cancer burden among Hispanic/Latinos receives grant from NCI

Collaborative program aims at reducing cancer burden among Hispanic/Latinos receives grant from NCI

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

UCSF researchers develop molecular 'on switch' that allows control over the actions of T cells

UCSF researchers develop molecular 'on switch' that allows control over the actions of T cells

Protein-coding gene identified as tumor suppressor for acute myeloid leukemia

Protein-coding gene identified as tumor suppressor for acute myeloid leukemia

Researchers reveal potential new treatment methods for fatal brain disease

Researchers reveal potential new treatment methods for fatal brain disease

JRC, CERN to explore potential of accelerator-driven method for producing targeted alpha therapy for cancer

JRC, CERN to explore potential of accelerator-driven method for producing targeted alpha therapy for cancer

Hyperbaric oxygen therapy improves outcomes of umbilical cord blood transplant patients

Hyperbaric oxygen therapy improves outcomes of umbilical cord blood transplant patients

Researchers develop promising metal-based compound to fight kidney cancer

Researchers develop promising metal-based compound to fight kidney cancer

Cattle virus found in human cancer cells

Cattle virus found in human cancer cells

Cancer-causing gene disrupts internal rhythm, metabolic pathways in cancer cells

Cancer-causing gene disrupts internal rhythm, metabolic pathways in cancer cells

Researchers establish link between bovine leukemia virus and human breast cancer

Researchers establish link between bovine leukemia virus and human breast cancer

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.